Literature DB >> 9395370

Aspergillus fumigatus conidia induce a Th1-type cytokine response.

M L Grazziutti1, J H Rex, R E Cowart, E J Anaissie, A Ford, C A Savary.   

Abstract

The response of human peripheral blood mononuclear cells (MNC) to Aspergillus fumigatus in vitro was evaluated. In studies of the proliferative response of MNC from 18 healthy donors to heat-killed A. fumigatus conidia, 15 displayed a significant response, with a stimulation index (SI) between 4 and 193. In contrast, all donors displayed a positive response to Candida albicans blastoconidia (SI ranged from 10 to 224). Despite the variability in reactivity to A. fumigatus conidia, the response of a particular individual was stable when retested over periods of 1-2 weeks. Supernatant from cocultures of A. fumigatus conidia with MNC contained increased levels of interferon-gamma, granulocyte-macrophage colony-stimulating factor, tumor necrosis factor-alpha, and interleukin (IL)-2, compared with unstimulated cells, but not IL-10 or IL-4. In addition, A. fumigatus induced lymphocyte surface expression of adhesion/activation-associated molecules. These results suggest that lymphocytes may contribute to host defense against Aspergillus by generating a Th1-type response.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9395370     DOI: 10.1086/514157

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  14 in total

1.  Characteristics of human dendritic cells generated in a microgravity analog culture system.

Authors:  C A Savary; M L Grazziuti; D Przepiorka; S P Tomasovic; B W McIntyre; D G Woodside; N R Pellis; D L Pierson; J H Rex
Journal:  In Vitro Cell Dev Biol Anim       Date:  2001-04       Impact factor: 2.416

2.  Role of IL-10 in invasive aspergillosis: increased resistance of IL-10 gene knockout mice to lethal systemic aspergillosis.

Authors:  K V Clemons; G Grunig; R A Sobel; L F Mirels; D M Rennick; D A Stevens
Journal:  Clin Exp Immunol       Date:  2000-11       Impact factor: 4.330

Review 3.  Aspergillus infections in transplant recipients.

Authors:  Nina Singh; David L Paterson
Journal:  Clin Microbiol Rev       Date:  2005-01       Impact factor: 26.132

4.  Generation of cytotoxic T cell responses directed to human leucocyte antigen Class I restricted epitopes from the Aspergillus f16 allergen.

Authors:  G Ramadan; B Davies; V P Kurup; C A Keever-Taylor
Journal:  Clin Exp Immunol       Date:  2005-04       Impact factor: 4.330

5.  Interleukin-12 enhances antifungal activity of human mononuclear phagocytes against Aspergillus fumigatus: implications for a gamma interferon-independent pathway.

Authors:  E Roilides; S Tsaparidou; I Kadiltsoglou; T Sein; T J Walsh
Journal:  Infect Immun       Date:  1999-06       Impact factor: 3.441

Review 6.  Aspergillus fumigatus and aspergillosis.

Authors:  J P Latgé
Journal:  Clin Microbiol Rev       Date:  1999-04       Impact factor: 26.132

7.  Early NK cell-derived IFN-{gamma} is essential to host defense in neutropenic invasive aspergillosis.

Authors:  Stacy J Park; Molly A Hughes; Marie Burdick; Robert M Strieter; Borna Mehrad
Journal:  J Immunol       Date:  2009-04-01       Impact factor: 5.422

8.  Binding of live conidia of Aspergillus fumigatus activates in vitro-generated human Langerhans cells via a lectin of galactomannan specificity.

Authors:  F Persat; N Noirey; J Diana; M-J Gariazzo; D Schmitt; S Picot; C Vincent
Journal:  Clin Exp Immunol       Date:  2003-09       Impact factor: 4.330

9.  Characterization of CD19(+)CD23(+)B2 lymphocytes in the allergic airways of BALB/c mice in response to the inhalation of Aspergillus fumigatus conidia.

Authors:  Sumit Ghosh; Scott A Hoselton; Jane M Schuh
Journal:  Open Immunol J       Date:  2012-12-28

10.  Serum opsonin ficolin-A enhances host-fungal interactions and modulates cytokine expression from human monocyte-derived macrophages and neutrophils following Aspergillus fumigatus challenge.

Authors:  Stefan Bidula; Darren W Sexton; Silke Schelenz
Journal:  Med Microbiol Immunol       Date:  2015-09-04       Impact factor: 3.402

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.